PCDH19 protocadherin 19
Gene ID: 57526, updated on 4-Jan-2025Gene type: protein coding
Also known as: DEE9; EFMR; EIEE9
- See all available tests in GTR for this gene
- Go to complete Gene record for PCDH19
- Go to Variation Viewer for PCDH19 variants
Summary
The protein encoded by this gene is a member of the delta-2 protocadherin subclass of the cadherin superfamily. The encoded protein is thought to be a calcium-dependent cell-adhesion protein that is primarily expressed in the brain. Mutations in this gene on human chromosome X are associated with sporadic infantile epileptic encephalopathy and to a female-restricted form of epilepsy (EFMR; also known as PCDH19RE). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
Associated conditions
See all available tests in GTR for this gene
Description | Tests |
---|---|
Developmental and epileptic encephalopathy, 9 | See labs |
Copy number response
Description |
---|
Copy number response Haploinsufficency Sufficient evidence for dosage pathogenicity (Last evaluated 2023-02-14) ClinGen Genome Curation PagePubMedTriplosensitivity No evidence available (Last evaluated 2023-02-14) ClinGen Genome Curation Page |
Genomic context
- Location:
- Xq22.1
- Sequence:
- Chromosome: X; NC_000023.11 (100291644..100410273, complement)
- Total number of exons:
- 6
Variation
Resource | Links for this gene |
---|---|
ClinVar | Variants reported to ClinVar |
dbVar | Studies and variants |
SNP | Variation Viewer for PCDH19 variants |
Genome viewer | Explore NCBI-annotated and select non-NCBI annotated genome assemblies |
- ClinVarRelated medical variations
- dbVarLink from Gene to dbVar
- MedGenRelated information in MedGen
- OMIMLink to related OMIM entry
- PCDH19 @ LOVD
- PubMed (OMIM)Gene links to PubMed derived from omim_pubmed_cited links
- RefSeq RNAsLink to Nucleotide RefSeq RNAs
- RefSeqGeneLink to Nucleotide RefSeqGenes
- Variation ViewerRelated Variants
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.